Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment [ J ] Diab Vasc Dis Res, 2012,9 (2) : 85-88.Gore MO, McGuire DK. Drugs for type 2 diabetes mellitus: The imperative for cardiovascular outcome assessment. Diabetes and Vascular Disease Research 2012; 9...
Drugs for type 2 diabetes mellitus: The imperative for cardiovascular outcome assessment. Diabetes and Vascular Disease Research 2012; 9(2): 85-88... MGDK Odettegore - 《Diabetes & Vascular Disease Research Official Journal of the International Society of Diabetes & Vascular Disease》 被引量: 0...
Cited by (37) Trends in Molecular Medicine Volume 26, Issue 6, June 2020, Pages 597-614ReviewType 2 Diabetes Mellitus Drugs for Alzheimer’s Disease: Current Evidence and Therapeutic Opportunities Author links open overlay panelLei Meng 1 2, Xin-Yu Li 1 2, Liang Shen 1 2, ...
1. Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug [J] . Nida Akhtar Current diabetes reviews . 2013,第6期 机译:2型糖尿病和Invokana:FDA批准的药物 2. In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T3151 mutant and wild-type ...
For clinical use, either alone or in combination with other antidiabetic agents, they should be taken before meals. 2, oral hypoglycemic drugs should pay attention to matters Oral hypoglycemic agents are the main force in the treatment of diabetes mellitus. They are mainly used in type 2 ...
The FDA has approved two new drugs of the thiazolidinedione class to treat type 2 diabetes mellitus. Rosiglitazone (Avandia, SmithKline Beecham, Philadelphia) is approved as monotherapy or in combination with metformin. Pioglitazone (Actos, Takeda Pharmaceuticals America Inc and Eli Lilly, Indianapolis)...
糖尿病治疗药物(Diabetestreatmentdrugs)ClinicalapplicationoforalantidiabeticdrugsAbstractObjective:torevealtheresearchprogressoforalantidiabeticdrugsandtopromoteitsrationaluseinclinic.Methods:theliteraturesaboutoraltreatmentoftype2diabetesmellitusinChinawereanalyzedandsummarizedinrecent3years.Results:theclinicaluseoforalanti...
OBJECTIVE: To analyze the outpatient use of oral hypoglycemic drugs for patients with type 2 diabetes mellitus in Henan Puyang Oilfield General Hospital( hereinafter referred to as "our hospital ") in order to provide reference for clinical rational use of hypoglycemic drugs in patients with type ...
sulfonylureas.Sulfonylureasareunsuitableforthefollowing: type1.1diabetesmellitus.2.pregnancyandlactation.3. severehepaticandrenaldysfunction.Mildrenalinsufficiency canonlybeusedwithsugar,Ping,Connaughtanddragon,and noothersulfonylureaantidiabeticdrugscanbeused.4. ...
Diabetes, specifically type 2 diabetes mellitus (T2DM), one of the most common non-communicable diseases,poses a major health problem throughout the world.T2DM is characterized by insulin resistance, impaired glucose-induced insulin secretion and inappropriately regulated glucagon secretion which in combin...